Skip to main content

Your search for “Novel Treatment” returned 433 results

Existing Heart Failure Drug May Treat Potential COVID-19 Long-Hauler Symptom

February 15, 2021

UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 1, 2019

Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.

UC San Diego Scientists Investigate Global Hemorrhagic Fever Bacterial Disease

September 1, 2015

An international research team, headed by Joseph Vinetz, MD, professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies…

Scientists Discover New Genetic Forms of Neurodegeneration

January 30, 2014

In a study published in the January 31, 2014 issue of Science, an international team led by scientists at the University of California, San Diego School of Medicine report doubling the number of known causes for the neurodegenerative disorder known as hereditary spastic paraplegia.

Tau-Associated MAPT Gene Increases Risk for Alzheimer’s Disease

February 17, 2015

…including Parkinson’s disease (PD) and AD. These findings provide novel insight into Alzheimer’s neurodegeneration, possibly opening the door for improved clinical diagnosis and treatment.

Rethinking Remdesivir

August 2, 2021

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout

December 13, 2022

UC San Diego scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis.

Promise Put to the Test

October 20, 2014

UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve potential therapies for spinal cord injuries, Type 1 diabetes and chronic lymphocytic leukemia.

Novel Phage Therapy Saves Patient with Multidrug-Resistant Bacterial Infection

April 25, 2017

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages — viruses that target and…

Researchers Uncover Surprising Link Between Body Temperature and Depression

February 5, 2024

People with depression have higher body temperatures, a finding that supports nascent research suggesting a mental health benefit to lowering the temperatures of those with the disorder, a new research team that includes scientists at the University of California San Diego found.

Category navigation with Social links